Cargando…

Emerging biomarkers of prostate cancer (Review)

Prostate cancer progression involves activation of signaling pathways controlling cell proliferation, apoptosis, anoikis, angiogenesis and metastasis. The current PSA-based test for the diagnosis of prostate cancer lacks sensitivity and specificity, resulting in missed diagnoses and unnecessary biop...

Descripción completa

Detalles Bibliográficos
Autores principales:	MARTIN, SARAH K., VAUGHAN, TAYLOR B., ATKINSON, TIMOTHY, ZHU, HAINING, KYPRIANOU, NATASHA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693823/ https://www.ncbi.nlm.nih.gov/pubmed/22641253 http://dx.doi.org/10.3892/or.2012.1832

Ejemplares similares

Inflammation in prostate cancer progression and therapeutic targeting
por: Stark, Timothy, et al.
Publicado: (2015)

A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review)
por: LACY, JOHN M., et al.
Publicado: (2014)

Mechanisms navigating the TGF-β pathway in prostate cancer
por: Cao, Zheng, et al.
Publicado: (2015)

Profiling Prostate Cancer Therapeutic Resistance
por: Wade, Cameron A., et al.
Publicado: (2018)

Deciphering Evolutionary Dynamics and Lineage Plasticity in Aggressive Prostate Cancer
por: Kyprianou, Natasha, et al.
Publicado: (2021)

Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance
por: Archer, Maddison, et al.
Publicado: (2020)

Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
por: Kahn, Barbara, et al.
Publicado: (2014)

Epigenetic mechanisms underlying subtype heterogeneity and tumor recurrence in prostate cancer
por: Chakraborty, Goutam, et al.
Publicado: (2023)

Anoikis in phenotypic reprogramming of the prostate tumor microenvironment
por: Nepali, Prerna R., et al.
Publicado: (2023)

Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
por: Grant, Campbell M., et al.
Publicado: (2013)

Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance
por: Altschuler, Joshua, et al.
Publicado: (2021)

Emerging proteomics biomarkers and prostate cancer burden in Africa
por: Adeola, Henry A., et al.
Publicado: (2017)

Prostate tumor neuroendocrine differentiation via EMT: The road less traveled
por: Dicken, Haley, et al.
Publicado: (2019)

Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer
por: Gaglani, Simita, et al.
Publicado: (2021)

Circadian Rhythm Disruption as a Contributor to Racial Disparities in Prostate Cancer
por: Dasari, Sonali S., et al.
Publicado: (2022)

Emerging biomarkers in the diagnosis of prostate cancer
por: Filella, Xavier, et al.
Publicado: (2018)

Novel Pharmacologic Targeting of Tight Junctions and Focal Adhesions in Prostate Cancer Cells
por: Hensley, Patrick J., et al.
Publicado: (2014)

Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells
por: Cao, Zheng, et al.
Publicado: (2017)

Identification of prostate cancer specific methylation biomarkers from a multi-cancer analysis
por: Pu, Yiyi, et al.
Publicado: (2021)

Emerging Biomarker-Guided Therapies in Prostate Cancer
por: Deluce, Jasna E., et al.
Publicado: (2022)

The Promise of Novel Molecular Markers in Bladder Cancer
por: Miremami, Jahan, et al.
Publicado: (2014)

Homeless Cells Escape Death and Deliver Lethal Cancer
por: Archer, Maddison, et al.
Publicado: (2021)

Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
por: Chakravarty, Dimple, et al.
Publicado: (2020)

Association between Expression of Connective Tissue Genes and Prostate Cancer Growth and Progression
por: Treacy, Patrick-Julien, et al.
Publicado: (2023)

Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists
por: Dovey, Zachary, et al.
Publicado: (2020)

Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer
por: Chen, Tzu-Yi, et al.
Publicado: (2023)

Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target
por: Liu, Guoqiang, et al.
Publicado: (2023)

Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients
por: Pavlova, Ina P., et al.
Publicado: (2021)

Volatilomics: An Emerging and Promising Avenue for the Detection of Potential Prostate Cancer Biomarkers
por: Berenguer, Cristina V., et al.
Publicado: (2022)

Molecular Signatures in Urologic Tumors
por: Larkin, Spencer, et al.
Publicado: (2013)

What is the Need for Prostatic Biomarkers in Prostate Cancer Management?
por: Spahn, Martin, et al.
Publicado: (2015)

Narrative review of urinary glycan biomarkers in prostate cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2021)

Nuclear spindles pave the way to metastasis
por: Hensley, Patrick J., et al.
Publicado: (2017)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma
por: Anker, Jonathan, et al.
Publicado: (2021)

Metabolomics Biomarkers of Prostate Cancer: A Systematic Review
por: Kdadra, Marouane, et al.
Publicado: (2019)

The association of prostatic lipids with progression, racial disparity and discovery of biomarkers in prostate cancer
por: Zhou, Xinchun, et al.
Publicado: (2021)

Kallikreins as Biomarkers for Prostate Cancer
por: Hong, Sung Kyu
Publicado: (2014)

Genomic biomarkers in prostate cancer
por: Kornberg, Zachary, et al.
Publicado: (2018)

Quinazoline-based α1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-β signalling and IκBα induction
por: Partin, J V, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_j8q7l36hrbjo1h2v69unis9srg